CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-label Extension Study to Assess Efficacy, Safety and Tolerability of Canakinumab and the Efficacy and Safety of Childhood Vaccinations in Patients With Cryopyrin Associated Periodic Syndromes (CAPS)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01576367
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:09.156683+00:00
Published At: 2016-08-03T00:00:00+00:00
Record Updated At: 2018-09-11
Results Posted At: 2016-08-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Cryopyrin-associated Periodic Syndromes", "Familial Cold Autoinflammatory Syndrome", "Muckle-Wells Syndrome", "Neonatal Onset Multisystem Inflammatory Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-09-11"
protocolSection.identificationModule.nctId: "NCT01576367"
protocolSection.identificationModule.officialTitle: "An Open-label Extension Study to Assess Efficacy, Safety and Tolerability of Canakinumab and the Efficacy and Safety of Childhood Vaccinations in Patients With Cryopyrin Associated Periodic Syndromes (CAPS)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2016-08-03"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.